nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorothiazide—Tubulointerstitial nephritis—Vandetanib—thyroid cancer	0.0413	0.0413	CcSEcCtD
Chlorothiazide—Respiratory distress—Sorafenib—thyroid cancer	0.0336	0.0336	CcSEcCtD
Chlorothiazide—Tubulointerstitial nephritis—Sorafenib—thyroid cancer	0.0279	0.0279	CcSEcCtD
Chlorothiazide—Pancreatitis—Vandetanib—thyroid cancer	0.0195	0.0195	CcSEcCtD
Chlorothiazide—Photosensitivity reaction—Vandetanib—thyroid cancer	0.0181	0.0181	CcSEcCtD
Chlorothiazide—Hyperglycaemia—Vandetanib—thyroid cancer	0.0179	0.0179	CcSEcCtD
Chlorothiazide—Pneumonia—Vandetanib—thyroid cancer	0.0178	0.0178	CcSEcCtD
Chlorothiazide—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.0175	0.0175	CcSEcCtD
Chlorothiazide—Renal failure—Vandetanib—thyroid cancer	0.0174	0.0174	CcSEcCtD
Chlorothiazide—Haematuria—Vandetanib—thyroid cancer	0.0169	0.0169	CcSEcCtD
Chlorothiazide—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.0164	0.0164	CcSEcCtD
Chlorothiazide—Erythema multiforme—Vandetanib—thyroid cancer	0.015	0.015	CcSEcCtD
Chlorothiazide—Alopecia—Vandetanib—thyroid cancer	0.014	0.014	CcSEcCtD
Chlorothiazide—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.0139	0.0139	CcSEcCtD
Chlorothiazide—Muscle spasms—Vandetanib—thyroid cancer	0.0133	0.0133	CcSEcCtD
Chlorothiazide—Pancreatitis—Sorafenib—thyroid cancer	0.0131	0.0131	CcSEcCtD
Chlorothiazide—Vision blurred—Vandetanib—thyroid cancer	0.013	0.013	CcSEcCtD
Chlorothiazide—Erectile dysfunction—Sorafenib—thyroid cancer	0.0123	0.0123	CcSEcCtD
Chlorothiazide—Pneumonia—Sorafenib—thyroid cancer	0.012	0.012	CcSEcCtD
Chlorothiazide—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.0118	0.0118	CcSEcCtD
Chlorothiazide—Renal failure—Sorafenib—thyroid cancer	0.0117	0.0117	CcSEcCtD
Chlorothiazide—Jaundice—Sorafenib—thyroid cancer	0.0116	0.0116	CcSEcCtD
Chlorothiazide—Thrombocytopenia—Vandetanib—thyroid cancer	0.0111	0.0111	CcSEcCtD
Chlorothiazide—Paraesthesia—Vandetanib—thyroid cancer	0.0101	0.0101	CcSEcCtD
Chlorothiazide—Erythema multiforme—Sorafenib—thyroid cancer	0.0101	0.0101	CcSEcCtD
Chlorothiazide—Decreased appetite—Vandetanib—thyroid cancer	0.00981	0.00981	CcSEcCtD
Chlorothiazide—Glycosuria—Epirubicin—thyroid cancer	0.00974	0.00974	CcSEcCtD
Chlorothiazide—Constipation—Vandetanib—thyroid cancer	0.00965	0.00965	CcSEcCtD
Chlorothiazide—Alopecia—Sorafenib—thyroid cancer	0.00947	0.00947	CcSEcCtD
Chlorothiazide—Erythema—Sorafenib—thyroid cancer	0.00933	0.00933	CcSEcCtD
Chlorothiazide—Glycosuria—Doxorubicin—thyroid cancer	0.00901	0.00901	CcSEcCtD
Chlorothiazide—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00898	0.00898	CcSEcCtD
Chlorothiazide—Muscle spasms—Sorafenib—thyroid cancer	0.00897	0.00897	CcSEcCtD
Chlorothiazide—Body temperature increased—Vandetanib—thyroid cancer	0.00892	0.00892	CcSEcCtD
Chlorothiazide—Hyperuricaemia—Epirubicin—thyroid cancer	0.0085	0.0085	CcSEcCtD
Chlorothiazide—Leukopenia—Sorafenib—thyroid cancer	0.00835	0.00835	CcSEcCtD
Chlorothiazide—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00831	0.00831	CcSEcCtD
Chlorothiazide—Asthenia—Vandetanib—thyroid cancer	0.0081	0.0081	CcSEcCtD
Chlorothiazide—Blood uric acid increased—Epirubicin—thyroid cancer	0.00803	0.00803	CcSEcCtD
Chlorothiazide—Hyperuricaemia—Doxorubicin—thyroid cancer	0.00787	0.00787	CcSEcCtD
Chlorothiazide—Diarrhoea—Vandetanib—thyroid cancer	0.00772	0.00772	CcSEcCtD
Chlorothiazide—Anaphylactic shock—Sorafenib—thyroid cancer	0.00761	0.00761	CcSEcCtD
Chlorothiazide—Dizziness—Vandetanib—thyroid cancer	0.00746	0.00746	CcSEcCtD
Chlorothiazide—Thrombocytopenia—Sorafenib—thyroid cancer	0.00745	0.00745	CcSEcCtD
Chlorothiazide—Blood uric acid increased—Doxorubicin—thyroid cancer	0.00743	0.00743	CcSEcCtD
Chlorothiazide—Aplastic anaemia—Epirubicin—thyroid cancer	0.0074	0.0074	CcSEcCtD
Chlorothiazide—Anorexia—Sorafenib—thyroid cancer	0.00726	0.00726	CcSEcCtD
Chlorothiazide—Vomiting—Vandetanib—thyroid cancer	0.00718	0.00718	CcSEcCtD
Chlorothiazide—Rash—Vandetanib—thyroid cancer	0.00712	0.00712	CcSEcCtD
Chlorothiazide—Dermatitis—Vandetanib—thyroid cancer	0.00711	0.00711	CcSEcCtD
Chlorothiazide—Headache—Vandetanib—thyroid cancer	0.00707	0.00707	CcSEcCtD
Chlorothiazide—Pulmonary oedema—Epirubicin—thyroid cancer	0.00702	0.00702	CcSEcCtD
Chlorothiazide—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00685	0.00685	CcSEcCtD
Chlorothiazide—Nausea—Vandetanib—thyroid cancer	0.0067	0.0067	CcSEcCtD
Chlorothiazide—Decreased appetite—Sorafenib—thyroid cancer	0.00662	0.00662	CcSEcCtD
Chlorothiazide—Photosensitivity—Epirubicin—thyroid cancer	0.00652	0.00652	CcSEcCtD
Chlorothiazide—Constipation—Sorafenib—thyroid cancer	0.00651	0.00651	CcSEcCtD
Chlorothiazide—Pulmonary oedema—Doxorubicin—thyroid cancer	0.0065	0.0065	CcSEcCtD
Chlorothiazide—Vascular purpura—Epirubicin—thyroid cancer	0.0064	0.0064	CcSEcCtD
Chlorothiazide—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00607	0.00607	CcSEcCtD
Chlorothiazide—Urticaria—Sorafenib—thyroid cancer	0.00605	0.00605	CcSEcCtD
Chlorothiazide—Photosensitivity—Doxorubicin—thyroid cancer	0.00603	0.00603	CcSEcCtD
Chlorothiazide—Body temperature increased—Sorafenib—thyroid cancer	0.00602	0.00602	CcSEcCtD
Chlorothiazide—Purpura—Epirubicin—thyroid cancer	0.00594	0.00594	CcSEcCtD
Chlorothiazide—Vascular purpura—Doxorubicin—thyroid cancer	0.00592	0.00592	CcSEcCtD
Chlorothiazide—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00561	0.00561	CcSEcCtD
Chlorothiazide—Hypersensitivity—Sorafenib—thyroid cancer	0.00561	0.00561	CcSEcCtD
Chlorothiazide—Purpura—Doxorubicin—thyroid cancer	0.0055	0.0055	CcSEcCtD
Chlorothiazide—Asthenia—Sorafenib—thyroid cancer	0.00546	0.00546	CcSEcCtD
Chlorothiazide—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00523	0.00523	CcSEcCtD
Chlorothiazide—Diarrhoea—Sorafenib—thyroid cancer	0.00521	0.00521	CcSEcCtD
Chlorothiazide—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00516	0.00516	CcSEcCtD
Chlorothiazide—Dizziness—Sorafenib—thyroid cancer	0.00503	0.00503	CcSEcCtD
Chlorothiazide—Pancreatitis—Epirubicin—thyroid cancer	0.00485	0.00485	CcSEcCtD
Chlorothiazide—Vomiting—Sorafenib—thyroid cancer	0.00484	0.00484	CcSEcCtD
Chlorothiazide—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00484	0.00484	CcSEcCtD
Chlorothiazide—Rash—Sorafenib—thyroid cancer	0.0048	0.0048	CcSEcCtD
Chlorothiazide—Dermatitis—Sorafenib—thyroid cancer	0.0048	0.0048	CcSEcCtD
Chlorothiazide—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00477	0.00477	CcSEcCtD
Chlorothiazide—Headache—Sorafenib—thyroid cancer	0.00477	0.00477	CcSEcCtD
Chlorothiazide—Nausea—Sorafenib—thyroid cancer	0.00452	0.00452	CcSEcCtD
Chlorothiazide—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00452	0.00452	CcSEcCtD
Chlorothiazide—Pancreatitis—Doxorubicin—thyroid cancer	0.00449	0.00449	CcSEcCtD
Chlorothiazide—Hyperglycaemia—Epirubicin—thyroid cancer	0.00446	0.00446	CcSEcCtD
Chlorothiazide—Pneumonia—Epirubicin—thyroid cancer	0.00444	0.00444	CcSEcCtD
Chlorothiazide—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00437	0.00437	CcSEcCtD
Chlorothiazide—Renal failure—Epirubicin—thyroid cancer	0.00434	0.00434	CcSEcCtD
Chlorothiazide—Jaundice—Epirubicin—thyroid cancer	0.0043	0.0043	CcSEcCtD
Chlorothiazide—Haematuria—Epirubicin—thyroid cancer	0.00421	0.00421	CcSEcCtD
Chlorothiazide—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00418	0.00418	CcSEcCtD
Chlorothiazide—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00413	0.00413	CcSEcCtD
Chlorothiazide—Agranulocytosis—Epirubicin—thyroid cancer	0.00412	0.00412	CcSEcCtD
Chlorothiazide—Pneumonia—Doxorubicin—thyroid cancer	0.00411	0.00411	CcSEcCtD
Chlorothiazide—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00405	0.00405	CcSEcCtD
Chlorothiazide—Renal failure—Doxorubicin—thyroid cancer	0.00401	0.00401	CcSEcCtD
Chlorothiazide—Jaundice—Doxorubicin—thyroid cancer	0.00398	0.00398	CcSEcCtD
Chlorothiazide—Haematuria—Doxorubicin—thyroid cancer	0.00389	0.00389	CcSEcCtD
Chlorothiazide—Agranulocytosis—Doxorubicin—thyroid cancer	0.00381	0.00381	CcSEcCtD
Chlorothiazide—Erythema multiforme—Epirubicin—thyroid cancer	0.00374	0.00374	CcSEcCtD
Chlorothiazide—Alopecia—Epirubicin—thyroid cancer	0.0035	0.0035	CcSEcCtD
Chlorothiazide—Erythema multiforme—Doxorubicin—thyroid cancer	0.00346	0.00346	CcSEcCtD
Chlorothiazide—Erythema—Epirubicin—thyroid cancer	0.00345	0.00345	CcSEcCtD
Chlorothiazide—Muscle spasms—Epirubicin—thyroid cancer	0.00331	0.00331	CcSEcCtD
Chlorothiazide—Vision blurred—Epirubicin—thyroid cancer	0.00325	0.00325	CcSEcCtD
Chlorothiazide—Alopecia—Doxorubicin—thyroid cancer	0.00324	0.00324	CcSEcCtD
Chlorothiazide—Erythema—Doxorubicin—thyroid cancer	0.00319	0.00319	CcSEcCtD
Chlorothiazide—Agitation—Epirubicin—thyroid cancer	0.00317	0.00317	CcSEcCtD
Chlorothiazide—Vertigo—Epirubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Chlorothiazide—Leukopenia—Epirubicin—thyroid cancer	0.00309	0.00309	CcSEcCtD
Chlorothiazide—Muscle spasms—Doxorubicin—thyroid cancer	0.00307	0.00307	CcSEcCtD
Chlorothiazide—Vision blurred—Doxorubicin—thyroid cancer	0.00301	0.00301	CcSEcCtD
Chlorothiazide—Agitation—Doxorubicin—thyroid cancer	0.00293	0.00293	CcSEcCtD
Chlorothiazide—Vertigo—Doxorubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Chlorothiazide—Leukopenia—Doxorubicin—thyroid cancer	0.00286	0.00286	CcSEcCtD
Chlorothiazide—Anaphylactic shock—Epirubicin—thyroid cancer	0.00281	0.00281	CcSEcCtD
Chlorothiazide—Thrombocytopenia—Epirubicin—thyroid cancer	0.00276	0.00276	CcSEcCtD
Chlorothiazide—Anorexia—Epirubicin—thyroid cancer	0.00268	0.00268	CcSEcCtD
Chlorothiazide—Hypotension—Epirubicin—thyroid cancer	0.00263	0.00263	CcSEcCtD
Chlorothiazide—Anaphylactic shock—Doxorubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Chlorothiazide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00255	0.00255	CcSEcCtD
Chlorothiazide—Paraesthesia—Epirubicin—thyroid cancer	0.00253	0.00253	CcSEcCtD
Chlorothiazide—Anorexia—Doxorubicin—thyroid cancer	0.00248	0.00248	CcSEcCtD
Chlorothiazide—Decreased appetite—Epirubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Chlorothiazide—Hypotension—Doxorubicin—thyroid cancer	0.00243	0.00243	CcSEcCtD
Chlorothiazide—Constipation—Epirubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Chlorothiazide—Paraesthesia—Doxorubicin—thyroid cancer	0.00234	0.00234	CcSEcCtD
Chlorothiazide—Decreased appetite—Doxorubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Chlorothiazide—Urticaria—Epirubicin—thyroid cancer	0.00224	0.00224	CcSEcCtD
Chlorothiazide—Constipation—Doxorubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Chlorothiazide—Body temperature increased—Epirubicin—thyroid cancer	0.00222	0.00222	CcSEcCtD
Chlorothiazide—Hypersensitivity—Epirubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Chlorothiazide—Urticaria—Doxorubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Chlorothiazide—Body temperature increased—Doxorubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Chlorothiazide—Asthenia—Epirubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Chlorothiazide—Diarrhoea—Epirubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Chlorothiazide—Hypersensitivity—Doxorubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Chlorothiazide—Asthenia—Doxorubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Chlorothiazide—Dizziness—Epirubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Chlorothiazide—Vomiting—Epirubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Chlorothiazide—Diarrhoea—Doxorubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Chlorothiazide—Rash—Epirubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Chlorothiazide—Dermatitis—Epirubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Chlorothiazide—Headache—Epirubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Chlorothiazide—Dizziness—Doxorubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Chlorothiazide—Nausea—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Chlorothiazide—Vomiting—Doxorubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Chlorothiazide—Rash—Doxorubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Chlorothiazide—Dermatitis—Doxorubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Chlorothiazide—Headache—Doxorubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Chlorothiazide—Nausea—Doxorubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
